FEATURES OF USE OF NANOTROPIL IN THE TREATMENT OF CHRONIC VERTEBROBASILAR INSUFFICIENCY
Keywords:
brain, stroke, ischemia, arteryAbstract
Aim. To study the role of nanotropil in the treatment of chronic vertebrobasilar insufficiency.
Materials and methods. In the neurological department of the Samarkand branch of the Russian Research Center for Emergency Medicine, we examined 62 patients (32 men and 30 women, average age 61,2±1,5 years). We studied patients diagnosed with dyscirculatory encephalopathy stages II and III, whose clinical picture was predominantly characterized by vestibuloatactic syndrome and mild cognitive decline. The patients were divided into two groups - the main group (29 people) and the comparison group (33 people), who did not differ in age, gender, duration of the disease and its main clinical manifestations. Patients in the main group took nanotropil at a dose of 100 mg/day, orally, in the first half of the day for 30 days. Patients in the comparison group took piracetam 0,4 g 2 times a day (morning, lunch).
Results. As a result of the study, it was revealed that in patients of the main group by the 30th day of treatment, dizziness significantly decreased in 25 patients (83% of patients), a moderate decrease in dizziness was noted in 6 patients (17%), the manifestation of ataxic disorders significantly decreased in 14 patients (72%), moderate in 7 patients (28%). After a 30-day course of treatment with Nanotropil, a significant increase in the speed of movements in the hands was recorded (reciprocal coordination test), in contrast to patients in the comparison group.
Conclusion. The studied mechanism of neuromodulatory action, which ensures predictability of therapy and ease of use, undoubtedly increases the effectiveness of treatment of vertebrobasilar insufficiency and places the drug Nanotropil in the priority range in the complex treatment of this pathology.
References
Верещагин, Н.В. Патология вертебрально-базилярной сиситемы и нарушения мозгового кровообращения / Н.В. Верещагин. - М.: Медицина, 1980. -312 с.
Гусев Е.И. Ишемия головного мозга / Е.И. Гусев, В.И. Скворцова. - М.: Медицина, 2001. - 328 с.
Веселовский, В.П. Практическая вертебрология и мануальная терапия / В.П. Весе-ловский. - Рига, 1991. - 334 с.
Жулев, Н.М. Шейный остеохондроз. Синдром позвоночной артерии. Вертебро-базилярная недостаточность / Н.М. Жулев, Д.В. Кандыба, Н.А. Яковлев. - СПб., 2001. - 292 с.
Сборник научных трудов. / Ахапкина В. И. I научный конгресс молодых ученых в области медицины и биологии. -М. 2019г. -228с.
Левин, О. С. Основные лекарственные средства, применяемые в неврологии. М. «МЕДпресс-информ» 2009. - 351с.
Шмидт, И.Р. Вертеброгенный синдром позвоночной артерии / И.Р. Шмидт. - Новосибирск: 2001. - 299 с.
Камчатнов, П.Р. Клинико-патогенетические особенности синдрома вертебрально-базилярной недостаточности / П.Р. Камчатнов, Т.Н. Гордеева, А.А. Кабанов и др. // Журн. нев-рол. и психиат. (прилож. Инсульт). - 2003. - № 1.- С. 55-57.
Caplan L, Chung CS, Wityk R, Glass T, Tapia J, Pazdera L, Chang HM, Dashe J, Chaves C, Vemmos K, Leary M, Dewitt L, Pessin M. New England medical center posterior circulation stroke registry: I. Methods, data base, distribution of brain lesions, stroke mechanisms, and outcomes. J Clin Neurol. 2015 Apr;1(1):14-30.
Lima Neto AC, Bittar R, Gattas GS, Bor-Seng-Shu E, Oliveira ML, Monsanto RDC, Bittar LF. Pathophysiology and Diagnosis of Vertebrobasilar Insufficiency: A Review of the Literature. Int Arch Otorhinolaryngol. 2017 Jul;21(3):302-307.
Najafi MR, Toghianifar N, Abdar Esfahani M, Najafi MA, Mollakouchakian MJ. Dolichoectasia in vertebrobasilar arteries presented as transient ischemic attacks: A case report. ARYA Atheroscler. 2016 Jan;12(1):55-8.
Yuh SJ, Alkherayf F, Lesiuk H. Dolichoectasia of the vertebral basilar and internal carotid arteries: A case report and literature review. Surg Neurol Int. 2013;4:153.
Lou M, Caplan LR. Vertebrobasilar dilatative arteriopathy (dolichoectasia). Ann N Y Acad Sci. 2010 Jan;1184:121-33.
Go G, Hwang SH, Park IS, Park H. Rotational Vertebral Artery Compression : Bow Hunter's Syndrome. J Korean Neurosurg Soc. 2013 Sep;54(3):243-5.
Yang YJ, Chien YY, Cheng WC. Vertebrobasilar insufficiency related to cervical spondylosis. A case report and review of the literature. Changgeng Yi Xue Za Zhi. 1992 Jun;15(2):100-4.
Buch VP, Madsen PJ, Vaughan KA, Koch PF, Kung DK, Ozturk AK. Rotational vertebrobasilar insufficiency due to compression of a persistent first intersegmental vertebral artery variant: case report. J Neurosurg Spine. 2017 Feb;26(2):199-202.
Paşaoğlu L. Vertebrobasilar system computed tomographic angiography in central vertigo. Medicine (Baltimore). 2017 Mar;96(12):e6297.
Caplan LR. Atherosclerotic Vertebral Artery Disease in the Neck. Curr Treat Options Cardiovasc Med. 2003 Jul;5(3):251-256.
Compter A, van der Worp HB, Schonewille WJ, Vos JA, Boiten J, Nederkoorn PJ, Uyttenboogaart M, Lo RT, Algra A, Kappelle LJ., VAST investigators. Stenting versus medical treatment in patients with symptomatic vertebral artery stenosis: a randomised open-label phase 2 trial. Lancet Neurol. 2015 Jun;14(6):606-14.
Kocak B, Korkmazer B, Islak C, Kocer N, Kizilkilic O. Endovascular treatment of extracranial vertebral artery stenosis. World J Radiol. 2012 Sep 28;4(9):391-400.
Raheja A, Taussky P, Kumpati GS, Couldwell WT. Subclavian-to-Extracranial Vertebral Artery Bypass in a Patient With Vertebrobasilar Insufficiency: 3-Dimensional Operative Video. Oper Neurosurg (Hagerstown). 2018 Mar 01;14(3):312.
Henry M, Polydorou A, Henry I, Ad Polydorou I, Hugel IM, Anagnostopoulou S. Angioplasty and stenting of extracranial vertebral artery stenosis. Int Angiol. 2005 Dec;24(4):311-24.
